In 2023, Germany led European stem cell transplantation among in-patients with a share of 23.35%, showing a 2.01% increase from the previous year. Italy followed at 15.56%, France at 12.14% (despite a decrease of 2.4%), and the UK at 10.71% with a 2.77% rise. Spain, though, experienced a slight dip of 0.73%, standing at 8.68%. Noteworthy growth was seen in the Netherlands and Switzerland, both around 3.5%, with Romania and Estonia showing over 5% gains, underscoring a dynamic landscape in smaller economies.
Future trends highlight a potential shift in procedures distribution, with emerging technologies and cross-border healthcare collaborations possibly altering current shares. Countries exhibiting recent growth, like Romania and Estonia, could capitalize on their momentum with policy and infrastructure investments. Furthermore, technological advancements in stem cell transplantation might democratize the procedure across the region. Additionally, there might be increased emphasis on addressing cost-effectiveness and accessibility post the procedural innovations, potentially influencing the future shares among the countries.
Top countries in Stem Cell Transplantation Performed on In-Patients Share by Country (Units (Procedures))
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 23.35 | 2023 | +1.89% | +2.01% | View data |
| 2 | 2 Italy | 15.56 | 2023 | +0.76% | +0.76% | View data |
| 3 | 3 France | 12.14 | 2023 | -0.94% | -2.4% | View data |
| 4 | 4 United Kingdom | 10.71 | 2023 | +2.09% | +2.77% | View data |
| 5 | 5 Spain | 8.68 | 2023 | -1.03% | -0.73% | View data |
| 6 | 6 Netherlands | 4.93 | 2023 | +3.18% | +3.44% | View data |
| 7 | 7 Poland | 3.78 | 2023 | +3.14% | +0.39% | View data |
| 8 | 8 Belgium | 2.67 | 2023 | +0.5% | +0.9% | View data |
| 9 | 9 Switzerland | 2.45 | 2023 | +3.26% | +3.5% | View data |
| 10 | 10 Sweden | 2.18 | 2023 | +3.42% | +0.98% | View data |
